Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Natus Medical Incorporated stock
Learn how to easily invest in Natus Medical Incorporated stock.
Natus Medical Incorporated is a medical devices business based in the US. Natus Medical Incorporated shares (NTUS) are listed on the NASDAQ and all prices are listed in US Dollars. Natus Medical Incorporated employs 1,400 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Natus Medical Incorporated
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NTUS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Natus Medical Incorporated stock price (NASDAQ: NTUS)Use our graph to track the performance of NTUS stocks over time.
Natus Medical Incorporated shares at a glance
|Latest market close||$32.77|
|52-week range||$20.90 - $33.93|
|50-day moving average||$32.69|
|200-day moving average||$26.80|
|Wall St. target price||$36.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.38|
Buy Natus Medical Incorporated shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Natus Medical Incorporated stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Natus Medical Incorporated price performance over time
|1 week (2022-06-24)||0.37%|
|1 month (2022-06-02)||-0.33%|
|3 months (2022-04-01)||20.70%|
|6 months (2021-12-31)||38.10%|
|1 year (2021-07-02)||27.46%|
|2 years (2020-07-02)||49.29%|
|3 years (2019-07-02)||27.46%|
|5 years (2017-06-30)||37.3|
Is Natus Medical Incorporated stock undervalued or overvalued?
Valuing Natus Medical Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Natus Medical Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Natus Medical Incorporated's P/E ratio
Natus Medical Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 86x. In other words, Natus Medical Incorporated shares trade at around 86x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Natus Medical Incorporated's EBITDA
Natus Medical Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $58.3 million.
The EBITDA is a measure of a Natus Medical Incorporated's overall financial performance and is widely used to measure a its profitability.
Natus Medical Incorporated financials
|Revenue TTM||$478.3 million|
|Operating margin TTM||6.46%|
|Gross profit TTM||$279.9 million|
|Return on assets TTM||3.36%|
|Return on equity TTM||3.02%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Natus Medical Incorporated share dividends
We're not expecting Natus Medical Incorporated to pay a dividend over the next 12 months.
Natus Medical Incorporated share price volatility
Over the last 12 months, Natus Medical Incorporated's shares have ranged in value from as little as $20.9 up to $33.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Natus Medical Incorporated's is 0.235. This would suggest that Natus Medical Incorporated's shares are less volatile than average (for this exchange).
Natus Medical Incorporated overview
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals.
Natus Medical Incorporated in the news
INVESTIGATION ALERT: Halper Sadeh LLP Investigates NTUS, SIMO, HMTV, SWCH
Frequently asked questionsWhat percentage of Natus Medical Incorporated is owned by insiders or institutions?
Currently 1.949% of Natus Medical Incorporated shares are held by insiders and 96.352% by institutions. How many people work for Natus Medical Incorporated?
Latest data suggests 1,400 work at Natus Medical Incorporated. When does the fiscal year end for Natus Medical Incorporated?
Natus Medical Incorporated's fiscal year ends in December. Where is Natus Medical Incorporated based?
Natus Medical Incorporated's address is: 3150 Pleasant View Road, Middleton, WI, United States, 53562 What is Natus Medical Incorporated's ISIN number?
Natus Medical Incorporated's international securities identification number is: US6390501038 What is Natus Medical Incorporated's CUSIP number?
Natus Medical Incorporated's Committee on Uniform Securities Identification Procedures number is: 639050103
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert